AC
AGN

Axon Capital’s Allergan plc AGN Stock Holding History

Axon Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,600
Closed -$2.75M – 10
2018
Q4 		$2.75M Sell
20,600
-11,600
-36% -$1.9M 6.37% 7
2018
Q3 		$6.13M Sell
32,200
-34,500
-52% -$6.34M 9.34% 7
2018
Q2 		$11.1M Sell
66,700
-38,300
-36% -$6.15M 14.29% 1
2018
Q1 		$17.7M Buy
105,000
+18,500
+21% +$3.1M 16.69% 1
2017
Q4 		$14.2M Sell
86,500
-59,400
-41% -$10.7M 17.14% 1
2017
Q3 		$29.9M Buy
145,900
+36,000
+33% +$8.37M 24.91% 1
2017
Q2 		$26.7M Sell
109,900
-23,086
-17% -$5.42M 30.09% 1
2017
Q1 		$31.8M Hold
132,986
– – 31.76% 1
2016
Q4 		$27.9M Sell
132,986
-751,510
-85% -$156M 16.77% 2
2016
Q3 		$204M Buy
884,496
+139,383
+19% +$34.1M 43.22% 1
2016
Q2 		$172M Buy
745,113
+205,306
+38% +$47.3M 24.84% 1
2016
Q1 		$145M Buy
539,807
+20,179
+4% +$5.78M 15.87% 2
2015
Q4 		$162M Buy
519,628
+88,877
+21% +$26.5M 13.68% 1
2015
Q3 		$117M Buy
+430,751
New +$132M 9.08% 4

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Axon Capital's AGN Position: Q1 2019 in Review

Axon Capital sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 20,600 shares — an estimated $2.75M sold.

Axon Capital first reported a position in AGN in Q3 2015 and held it in 14 quarters. The position peaked at $204M in Q3 2016. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Axon Capital reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Axon Capital sold 20,600 Allergan plc shares in Q1 2019, an estimated $2.75M.
  • Axon Capital first reported a position in Allergan plc in Q3 2015 and held it in 14 quarters.
  • Axon Capital's Allergan plc position peaked at $204M in Q3 2016.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Axon Capital's 13F filing for Q1 2019, filed 15 May 2019.